Clinical Trial Update: FamilyLive Feasibility and Effectiveness Study [EARLY_Phase 1]

View source ↗

Summary

The FamilyLive feasibility and effectiveness study in mood lability and PTSD/Anxiety has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Post-traumatic Stress Disorder

Snippet

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Conditions: Mood Lability, PTSD | EARLY_Phase 1 | Status: WITHDRAWN